Annexon, Inc.

NASDAQ:ANNX

Biotechnology

Healthcare
$3.47 -0.71%

-$0.04 today

Market cap
$568.53M
Beta
1.18
P/E (TTM)
-4.8
EPS (TTM)
-$1.01
52W Low $1.85High $7.18

Volume 2.88M

Average 2.56M

Returns on capital

Annexon, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-97.7%

avg -47.5%

ROIC

-91.0%

avg -93.9%

ROA

-74.5%

avg -69.3%

Analysis

ROA is currently the strongest return metric at -74.5% versus its period average of -69.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Douglas Love

Chief Executive Officer, President & DirectorUSD 1.06M58390.48K0.33%

Dean R. Artis

Chief Scientific Officer & Executive Vice PresidentUSD 797.38K65——

Ted Yednock

Executive Vice President, Chief Innovation Officer & Chairman of the Scientific Advisory BoardUSD 737.79K680<0.01%

Jamie Dananberg

Executive Vice President & Chief Medical OfficerUSD 715.23K68123.58K0.10%

Jennifer Lew

Executive Vice President, Chief Financial Officer & Corporate SecretaryUSD 700.02K53170.70K0.14%

Michael Overdorf

Executive Vice President & Chief Business OfficerUSD 580.47K55182.63K0.15%

Henk-Andre Kroon

Senior Vice President of Translational Medicine————

Shikhar Agarwal

Senior Vice President & Head of Commercial————

Linda A. Fitzpatrick

Chief Human Resources Officer—69——

Sunil Mehta

Senior Vice President of Medical Affairs————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 24, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

12

$10.90M

Sells

10

$313,427.80

Net Transaction Value

+$10.58M

Net buying

Most Active

Satter Muneer A

5 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 24, 26

Love Douglas

Direct

Buy$99.8K
May 28, 26

Satter Muneer A

Indirect

Buy$3.3M
May 11, 26

Carson William H.

Direct

Buy$46.2K
Apr 10, 26

Carson William H.

Direct

Buy$49.6K
Mar 10, 26

Carson William H.

Direct

Buy$45.4K
Mar 2, 26

Dananberg Jamie

Direct

Sell$31.6K
Mar 2, 26

Overdorf Michael

Direct

Sell$23.5K
Mar 2, 26

Yednock Ted

Direct

Sell$30.2K
Mar 2, 26

ARTIS DEAN RICHARD

Direct

Sell$32K
Mar 2, 26

Lew Jennifer

Direct

Sell$30.2K

1–10 of 22

Summary

Insiders reported 12 buys worth $10.90M and 10 sells worth $313,427.80 over the last 12 months. That adds up to net buying of $10.58M. Satter Muneer A was the most active insider with 5 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A6 analysts
Net IncomeN/AN/AN/A
N/A6 analysts
EBITN/AN/AN/A
N/A6 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Annexon, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ANNX's management, answered from reported figures.

Who manages ANNX?

Annexon, Inc. (ANNX) lists 10 active executives. The top listed executive is Jamie Dananberg, Executive Vice President & Chief Medical Officer.

Are ANNX insiders buying or selling?

Recent insider activity shows net buying of $72.72M.